Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

June 14, 2021

AbbVie Completes $1.4B Purchase of Aliada

November 1, 2024

Marketing Authorization Granted for AbbVie’s Migraine Therapy Aquipta

September 5, 2023

Must Read

Top 10 Skills Every Life Sciences Professional Needs in 2026

May 11, 2026

How Are Life Sciences Companies Reducing Environmental Impact Across Supply Chains?

May 11, 2026

How Is Generative AI Changing Drug Discovery in 2026?

May 11, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

CellCentric Raises $220 Million Series D to Advance Inobrodib and Launch Phase 3 Myeloma Trial

Entrada Therapeutics Reports 2.36% Dystrophin Increase in Early DMD Trial Data

Myqorzo from Cytokinetics wins historic cardiomyopathy trial

Gedatolisib from Celcuity outperforms Piqray from Novartis in phase 3 research

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Top 10 Skills Every Life Sciences Professional Needs in 2026

How Are Life Sciences Companies Reducing Environmental Impact Across Supply Chains?

How Is Generative AI Changing Drug Discovery in 2026?

The Rise of AI-Powered Clinical Trials: What Pharma Leaders Need to Know

Insights

Patient-Centric Clinical Trials And The Role Of A Travel Concierge

Editor Picks

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

AbbVie Completes $1.4B Purchase of Aliada

Marketing Authorization Granted for AbbVie’s Migraine Therapy Aquipta

Must Read

Top 10 Skills Every Life Sciences Professional Needs in 2026

How Are Life Sciences Companies Reducing Environmental Impact Across Supply Chains?

How Is Generative AI Changing Drug Discovery in 2026?

Hot Topics

About Us

Follow Us